Biotech · Private company

Dyax Corp.

Track this companyFree. Adds Dyax Corp. to your Dealase workspace and tells you when its record changes.

Clinical trials30 recruiting or active

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Clinical trials3

Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAEPHASE3 · COMPLETED · started Mar 3, 2016ClinicalTrials.gov NCT02586805 · fetched Nov 12, 2026
A Single Increasing Dose Study to Assess Safety and Tolerability of DX-2930 in Healthy SubjectsPHASE1 · COMPLETED · started Aug 12, 2013ClinicalTrials.gov NCT01923207 · fetched Nov 12, 2026
Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary AngioedemaPHASE2 · WITHDRAWN · started Aug 1, 2013ClinicalTrials.gov NCT01832896 · fetched Nov 12, 2026